Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Watanabe, T. Harada, T. Hirota, K. Nabeshima, M. Fujita, N. Nagata (Fukuoka, Japan). Forced vital capacity decreases rapidly in patients with idiopathic upper lobe-dominant pulmonary fibrosis. Eur Respir J 2011; 38: Suppl. 55, 3750

Member's Comments

No comment yet.

Related content which might interest you: Coexistent pulmonary emphysema delays the decrease in vital capacity in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Forced vital capacity, total lung capacity and diffusion capacity in idiopathic pulmonary fibrosis Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Stability or improvement in forced vital capacity with nintedanib in patients with idiopathic pulmonary fibrosis Source: Eur Respir J, 52 (2) 1702593; 10.1183/13993003.02593-2017 Year: 2018 Spirometric evaluation of idiopathic pulmonary fibrosis (IPF): forced or slow vital capacity? Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis Source: Eur Respir J 2012; 40: 61-66 Year: 2012 Changing the idiopathic pulmonary fibrosis treatment approach and improving patient outcomes Source: Eur Respir Rev 2012; 21: 161-167 Year: 2012 Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis Source: Eur Respir J 2010; 35: 830-836 Year: 2010 Forced vital capacity (FVC) decline in idiopathic pulmonary fibrosis (IPF) – modelling the myth Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 Differences in FVC decline by extent of emphysema in patients with combined pulmonary fibrosis and emphysema (CPFE) syndrome Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015 Comparison of clinical characteristics and prognosis in patients with idiopathic pulmonary upper lobe predominant pulmonary fibrosis and idiopathic pulmonary fibrosis Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018 Changes in functional capacity after endoscopic lung volume reduction in patients with chronic obstructive lung disease and severe emphysema Source: International Congress 2018 – Endoscopic lung volume reduction Year: 2018 Diffuse pulmonary fibrosis and pulmonary emphysema associated with paradoxically normal spirometry Source: Eur Respir J 2006; 28: Suppl. 50, 100s Year: 2006 Clinical features of patients with idiopathic pulmonary upper lobe-dominant fibrosis Source: International Congress 2016 – Orphan diseases I Year: 2016 Exercise capacity in patients with bilateral diffuse bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 83s Year: 2001 Evaluation of functional capacity and pulmonary functions during acute pulmonary exacerbation in children with cystic fibrosis Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases Year: 2020 Forced oscillation technique reflects lung disease in young children with cystic fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 33s Year: 2007 Early decrease of forced vital capacity is a good prediction tool for prognosis in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Forced inspiratory volume in one second (FIV1) in the assessment of reversibility of airway obstruction in patients with chronic obstructive pulmonary disease (COPD) and in relation to the severity Source: Eur Respir J 2002; 20: Suppl. 38, 300s Year: 2002 Static lung compliance and DLCO often demonstrate parenchymal involvement in sarcoidosis despite a normal total lung capacity Source: Annual Congress 2009 - Sarcoidosis in review Year: 2009 Idiopathic pulmonary upper lobe fibrosis shows distinct features and poor prognosis compared to idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013